Tech Company Financing Transactions

Refoxy Pharma Funding Round

Boehringer Ingelheim Venture Fund, Apollo Health Ventures and High-Tech Gründerfonds participated in a $9.6 million Seed funding round for Refoxy Pharma. The round was announced by the company on 12/4/2024.

Transaction Overview

Company Information

Company Status

Private & Independent

Industry

Life Sciences

Mailing Address

Im Mediapark 5
Cologne, 50670
Germany

Phone

Undisclosed

Website

www.refoxy.com

Email Address

[email protected]

Overview

Refoxy has created a discovery platform that permits the identification and optimization of novel FOXO3 small molecule activators that are functionally relevant across diverse disease models. F.act finder (or FOXO activator finder) was built on top of the pioneering work of our scientific co-founder, Prof. Wolfgang Link, and relies on a combination of phenotypic screening, unbiased assessments of FOXO3 specificity, and multiple built-in safety and counter screening measurements.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Victor Bustos

        

Co-Founder

Wolfgang Link

        

Browse more venture capital transactions:

Prev: 12/4/2024: SmarTrak.Ai venture capital transaction
Next: 12/4/2024: HappyRobot venture capital transaction

Share this article

About Database of VC Transactions

We do our best to report on all VC transactions involving tech companies. VC transactions reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary